Back to search

University of British Columbia

Molecular mechanisms of SARS-CoV-2 variant spike proteins

Abstract

dc:description

SARS-CoV-2 exhibited limited widespread genetic variability over the first year of the COVID-19 pandemic. However, approximately one year after its emergence, a slew of variants would emerge, with the Alpha variant replacing the original Wuhan-Hu-1 lineage and Beta and Gamma variants emerging soon thereafter. These and subsequent variants (Epsilon, Kappa, Delta, Omicron, and XBB) are defined by numerous mutations within their spike (S) glycoprotein which is critical for viral infection via binding the human angiotensin converting enzyme (hACE2) receptor and is the sole protein immunogen in most COVID-19 vaccines (mRNA-1273 [Moderna] and BNT162 [Pfizer] for example). Therefore, mutations within the SARS-CoV-2 S protein impact both viral pathobiology and therapeutic measures to treat viral infection. We hypothesize that variant SARS-CoV-2 spike proteins exhibit enhanced receptor (hACE2) binding affinity and monoclonal and polyclonal antibody evasion. This thesis aims to characterize the Alpha, Beta, Gamma, Epsilon, Kappa, Delta, and Omicron (BA.1 and BA.2) variant S proteins for their ability to: i) enhance hACE2 binding, ii) evade monoclonal and patient-derived antibodies (elicited by either SARS-CoV-2 infection and/or vaccination), and iii) discover structural rationale that underly these changes. We find that each variant S protein exhibits distinctive characteristics - for example the Alpha S primarily exhibits enhanced hACE2 binding, while the Omicron S proteins demonstrate significant escape from antibodies and have acquired the unique ability to bind murine ACE2. The independent study of variant mutations in isolation and in combination provide insights into mutation epistasis and enable predictions into the behaviour of future SARS-CoV-2 variants of concern. Finally, we characterize a novel antibody fragment (ab6) whose epitope confers broad neutralization across variant of concern S proteins, presenting a potential variant-resistant therapeutic target.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biochemistry and Molecular Biology
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Saville, James William
Contributors dc:contributor
  • Subramaniam, Sriram

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-ShareAlike 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/87270

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Saville, James William. Molecular mechanisms of SARS-CoV-2 variant spike proteins. doctoral thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/87270